Yüklüyor......

Sequencing of nontransplant treatments in multiple myeloma patients with active disease

The approval of several different classes of drugs in recent years has resulted in a dramatic expansion of treatment options for multiple myeloma patients, improving both survival and quality of life. Lenalidomide and bortezomib are now core components of treatment both at time of diagnosis and at r...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Hematology Am Soc Hematol Educ Program
Asıl Yazarlar: Yee, Andrew J., Raje, Noopur S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2016
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6142445/
https://ncbi.nlm.nih.gov/pubmed/27913521
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!